Kisspeptin and GPR54 Receptor Expression in Endometrial Cancer Tissue

• Published in: Cancers 2023-02, Vol.15 (4), p.1228
• Main Authors: Gowkielewicz, Marek, Lipka, Aleksandra, Piotrowska, Aleksandra, Szadurska-Noga, Marta, Nowakowski, Jacek J, Lepiarczyk, Ewa, Wiszpolska, Marta, Waśniewski, Tomasz, Dzięgiel, Piotr, Kaleczyc, Jerzy, Majewski, Mariusz Krzysztof, Majewska, Marta
• Format: Article
• Language: English
• Subjects: Apoptosis; Automation; Birth weight; Body mass index; Breast feeding; Cancer; Cell division; Cell receptors; Contraception; Development and progression; Diabetes mellitus (non-insulin dependent); Endometrial cancer; Endometriosis; Endometrium; Gene expression; Genetic aspects; Gynecology; Health aspects; Hormone replacement therapy; Hypertension; Hysterectomy; Kiss1 protein; Ligands (Biochemistry); Medical prognosis; Melanoma; Menstrual cycle; Metastases; Metastasis; Neonates; Ovarian cancer; Patients; Peptides; Proteins; Puberty; Signal transduction; Spermatogenesis; Statistical analysis; Toxicity; Womens health
• ISSN: 2072-6694; 2072-6694
• DOI: 10.3390/cancers15041228

Kisspeptin (KISS) is a natural peptide-discovered in 1996 as a factor inhibiting the ability to metastasize in malignant melanoma. This protein plays also a regulatory role in the process of puberty, the menstrual cycle, spermatogenesis, implantation and development of the human placenta. The present study aimed to evaluate the expression of KISS and its receptor GPR54 in endometrial cancer (EC) tissue, depending on the histological type of cancer, its stage, various demographic characteristics, and clinical conditions in 214 hysterectomy patients. Expression of KISS and GPR54 was confirmed in 99.5% and 100% of the cases, respectively. Hormone replacement therapy and the coexistence of the anti-Müllerian type 2 receptor in cancer tissue enhanced KISS expression. Smoking, on the other hand, decreased KISS expression. GPR54 expression increased with the advancement of the disease (according to FIGO classification). Also, the presence of the anti-Müllerian type 2 receptor in EC increased the level of GPR54. Hypertension, age and miscarriage harmed the presence of GPR54. The histological type of cancer, diabetes type 2, body mass index, hormonal contraception, number of deliveries, birth weight of newborns, breastfeeding time, and the presence of AMH in EC tissue were not associated with the expression of either KISS nor GPR54. The KISS level was also significantly related to the GPR54 level. Considering that KISS is a non-toxic peptide with antimetastatic properties, further investigation is essential to determine the clinical significance of this peptide.